Catalog No.
RVV09904
Expression system
Mammalian Cells
Species reactivity
Vesicular stomatitis Indiana virus (strain San Juan) (VSIV)
Host species
Human
Isotype
VHH-hFc
Clonality
Monoclonal
Target
NP, Nucleoprotein, Nucleocapsid protein, Protein N
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P03521
Applications
FCM, IP
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
1001
Single dose VSV-based vaccine protects mice against lethal heterologous Crimean-Congo hemorrhagic fever virus challenge., PMID:40447644
Short-term oral exposure to nanoplastics does not significantly impact the antiviral immune response of the mouse., PMID:39854993
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories., PMID:39772242
Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVΔG-ZEBOV-GP)., PMID:36725433
A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants., PMID:34654739
Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector., PMID:30582589
Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development., PMID:29581897
Analysis of the humoral immune responses among cynomolgus macaque naturally infected with Reston virus during the 1996 outbreak in the Philippines., PMID:23057674
Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody., PMID:22139535
sGP serves as a structural protein in Ebola virus infection., PMID:21987767
Recombinant vesicular stomatitis virus expressing influenza nucleoprotein induces CD8 T-cell responses that enhance antibody-mediated protection after lethal challenge with influenza virus., PMID:19244472
A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice., PMID:16426712
Identification of a novel tripartite complex involved in replication of vesicular stomatitis virus genome RNA., PMID:12477878
Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response., PMID:10933697
Establishment and characterisation of a porcine rubulavirus (LPMV) persistent infection in porcine kidney cells., PMID:9444775
Replication and amplification of novel vesicular stomatitis virus minigenomes encoding viral structural proteins., PMID:7707520
A small highly basic protein is encoded in overlapping frame within the P gene of vesicular stomatitis virus., PMID:8388490
Major histocompatibility complex conformational epitopes are peptide specific., PMID:1281212
Protective vaccination against bovine leukaemia virus infection by means of cell-derived vaccine., PMID:1667347
Antiviral protection by CD8+ versus CD4+ T cells. CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL., PMID:1710246
Sequence analyses of the 3' genome end and NP gene of human parainfluenza type 2 virus: sequence variation of the gene-starting signal and the conserved 3' end., PMID:2173261
Tubulin: a factor necessary for the synthesis of both Sendai virus and vesicular stomatitis virus RNAs., PMID:3016702
For research use only. Not for human or drug use.
